Atlantic Healthcare is progressing alicaforsen enema in ulcerative colitis and oral tablet formulations for the treatment of Crohn’s disease and ulcerative colitis.

Renzapride has wide applicability for the treatment of GI motility disorders, many of which represent significant unmet medical needs.

Product Preclinical Phase 1 Phase 2
a      |      b
Phase 3 Regulatory Approval
Enema – Ulcerative Colitis
Tablet – Crohn’s
Tablet – Ulcerative Colitis
Rare disease – Systemic Scleroderma
Rare disease – Cystic Fibrosis
Rare disease – Undisclosed Indication

Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Disease (IBD) is caused by a chronic activation of the immune system in the gastrointestinal (GI) tract.

Ulcerative colitis (UC) is an autoimmune disease where the colon (large intestine or bowel) and rectum become inflamed.

Find out more

Crohn’s Disease is an autoimmune disease which can affect any part of the digestive system, from the mouth to the anus.

Find out more